BACKGROUND: Dideoxy-based chain termination sequencing developed by Sanger is the gold standard sequencing approach and allows clinical diagnostics of disorders with relatively low genetic heterogeneity. Recently, new next generation sequencing (NGS) technologies have found their way into diagnostic laboratories, enabling the sequencing of large targeted gene panels or exomes. The development of benchtop NGS instruments now allows the analysis of single genes or small gene panels, making these platforms increasingly competitive with Sanger sequencing. METHODS: We developed a generic automated ion semiconductor sequencing work flow that can be used in a clinical setting and can serve as a substitute for Sanger sequencing. Standard amplicon-based enrichment remained identical to PCR for Sanger sequencing. A novel postenrichment pooling strategy was developed, limiting the number of library preparations and reducing sequencing costs up to 70% compared to Sanger sequencing. RESULTS: A total of 1224 known pathogenic variants were analyzed, yielding an analytical sensitivity of 99.92% and specificity of 99.99%. In a second experiment, a total of 100 patient-derived DNA samples were analyzed using a blind analysis. The results showed an analytical sensitivity of 99.60% and specificity of 99.98%, comparable to Sanger sequencing. CONCLUSIONS: Ion semiconductor sequencing can be a first choice mutation scanning technique, independent of the genes analyzed.
BACKGROUND: Dideoxy-based chain termination sequencing developed by Sanger is the gold standard sequencing approach and allows clinical diagnostics of disorders with relatively low genetic heterogeneity. Recently, new next generation sequencing (NGS) technologies have found their way into diagnostic laboratories, enabling the sequencing of large targeted gene panels or exomes. The development of benchtop NGS instruments now allows the analysis of single genes or small gene panels, making these platforms increasingly competitive with Sanger sequencing. METHODS: We developed a generic automated ion semiconductor sequencing work flow that can be used in a clinical setting and can serve as a substitute for Sanger sequencing. Standard amplicon-based enrichment remained identical to PCR for Sanger sequencing. A novel postenrichment pooling strategy was developed, limiting the number of library preparations and reducing sequencing costs up to 70% compared to Sanger sequencing. RESULTS: A total of 1224 known pathogenic variants were analyzed, yielding an analytical sensitivity of 99.92% and specificity of 99.99%. In a second experiment, a total of 100 patient-derived DNA samples were analyzed using a blind analysis. The results showed an analytical sensitivity of 99.60% and specificity of 99.98%, comparable to Sanger sequencing. CONCLUSIONS: Ion semiconductor sequencing can be a first choice mutation scanning technique, independent of the genes analyzed.
Authors: Willeke A M Blokx; Katrin Rabold; H Jorn Bovenschen; Marjolijn J L Ligtenberg; Arjen R Mensenkamp; Gesina van Lijnschoten; Wendy A G van Zelst-Stams; Patricia J T A Groenen Journal: Virchows Arch Date: 2014-10-24 Impact factor: 4.064
Authors: Jun Yu; Yoshihiko Sadakari; Koji Shindo; Masaya Suenaga; Aaron Brant; Jose Alejandro Navarro Almario; Michael Borges; Thomas Barkley; Shahriar Fesharakizadeh; Madeline Ford; Ralph H Hruban; Eun Ji Shin; Anne Marie Lennon; Marcia Irene Canto; Michael Goggins Journal: Gut Date: 2016-07-18 Impact factor: 23.059
Authors: Chittibabu Vatte; Ali Mohammed Al Amri; Cyril Cyrus; Shahanas Chathoth; Ahmed Alsayyah; Arafat Ahmad; Mohammed Shakil Akhtar; Nada Fehaid Alrashidi; Nithya Jayaseeli; Hamed Al Wadani; Alhussain Al Zahrani; Amein Kadhem Al Ali Journal: Oncol Lett Date: 2019-07-04 Impact factor: 2.967
Authors: Paul D N Hebert; Thomas W A Braukmann; Sean W J Prosser; Sujeevan Ratnasingham; Jeremy R deWaard; Natalia V Ivanova; Daniel H Janzen; Winnie Hallwachs; Suresh Naik; Jayme E Sones; Evgeny V Zakharov Journal: BMC Genomics Date: 2018-03-27 Impact factor: 3.969
Authors: Zeinab Fadaie; Kornelia Neveling; Tuomo Mantere; Ronny Derks; Lonneke Haer-Wigman; Amber den Ouden; Michael Kwint; Luke O'Gorman; Dyon Valkenburg; Carel B Hoyng; Christian Gilissen; Lisenka E L M Vissers; Marcel Nelen; Frans P M Cremers; Alexander Hoischen; Susanne Roosing Journal: HGG Adv Date: 2021-07-20